Deregulation of host-microbiota interactions in the gut is a pivotal characteristic of Crohn's disease. It remains unclear, however, whether commensals and/or the dysbiotic microbiota associated with pathology in humans are causally involved in Crohn's pathogenesis. Here, we show that Crohn's-like ileitis in Tnf DARE/ þ mice is microbiota-dependent.
INTRODUCTION
A mutually beneficial relationship has been evolutionarily shaped in the mammalian gut between the host and the complex communities of commensal microorganisms, collectively called as the ''microbiota''. Misbalanced host-microbiota interactions are considered to underlie the pathogenesis of inflammatory bowel diseases (IBD), chronic inflammatory disorders of the intestine with two major forms, Crohn's disease and ulcerative colitis. 1 Crohn's disease is manifested primarily in the terminal ileum, a part of the intestinal tract that provides a unique microenvironment for the growth of microbial communities. Contrary to the large bowel, the ileum is characterized by the formation of a single-layered and porous mucus barrier, which is penetrant to bacteria. 2 Antimicrobial peptides secreted by Paneth cells localized at the basal part of the crypts and an extensive network of lymphoid tissues, including Peyer's patches and isolated lymphoid follicles, provide antimicrobial clearance and immunosurveillance. 3, 4 Furthermore, the composition of mucosa-associated microbial populations in the ileum significantly differs from that of the colon both in healthy humans and in IBD patients, 5 whereas a series of studies has established that Crohn's disease is associated with dysbiosis. 6 A recent relevant study showed that treatment-naive pediatric Crohn's disease associates with enrichment of Enterobacteriaceae and depletion of Clades IV and XIVa of Clostridia in the mucosa of the terminal ileum. 7 Apart from these microbial alterations associated with disease, genome-wide association studies have indicated several microbial recognition and host defense genes as associated with both Crohn's disease and ulcerative colitis. 8 For example, risk alleles in NOD2 and ATG16L1 genes lead in an additive manner to an abnormal Paneth cell phenotype in Crohn's disease patients, 9 indicative of a possible implication of defective microbial clearance in pathogenesis. Although recent progress in Crohn's disease genetics and microbiome analysis strengthens the concept that misbalanced host-microbiota interactions underlie pathogenesis and also establish the development of a dysbiotic microbiota as a key feature associated with pathology, the causalities in abnormal hostmicrobiota interactions with regard to Crohn's disease pathogenesis remain unknown.
Mouse models of IBD are essential for the understanding of mechanisms implicating host-microbiota interactions in human disease; however, relevant studies have been restricted in colitis models so far. 10 Tnf DARE/ þ mice chronically overproduce tumor necrosis factor (TNF) and spontaneously develop a fully penetrant Crohn's-like IBD pathology localized specifically in the terminal ileum and occasionally also in the proximal colon. 11 Tnf DARE/ þ mice display typical histopathological features of human Crohn's disease such as massive infiltration of acute and chronic effector cells in the lamina propria (LP), villi blunting, and development of transmural inflammation. 11 Local overexpression of TNF in the gut specifically by intestinal epithelial cells (IECs) is sufficient to induce full-blown Crohn's-like IBD pathology in this model. 12 Thus, the Tnf DARE model is an ideal tool for the study of intestinal epithelial responses to luminal bacteria and vice versa, in a disease context sharing many common characteristics with human Crohn's disease.
Here, we study host-microbiota interactions in murine modeled Crohn's disease and demonstrate that pathology in Tnf DARE/ þ mice depends on the presence of the commensal microbiota that is required for TNF overexpression in the intestine. We also evidence epithelial alterations occurring in established but not in early disease in Tnf DARE/ þ mice and show that a dysbiotic microbiota is shaped in diseased mice. Our results suggest that commensals are sufficient to initiate Crohn's disease pathogenesis in the presence of pro-inflammatory genetic alterations, whereas an overall dysbiotic microbiota with significant alterations at the level of phyla develops in the inflamed mucosa secondarily to disease and is not required for disease initiation.
RESULTS
Crohn's-like IBD pathology and disease-initiating TNF overexpression in the intestine of Tnf DARE/ þ mice depend on the presence of bacteria
To examine the role of the intestinal microbiota in Crohn's disease pathogenesis, we generated germ-free Tnf DARE/ þ mice and compared disease development with Tnf DARE/ þ mice reared under specific pathogen-free conditions. Strikingly, germ-free Tnf DARE/ þ mice were completely protected from IBD pathology showing no signs of inflammatory infiltration or villi blunting in the terminal ileum as evidenced by histological analysis at the age of 15 weeks, an age when Tnf DARE/ þ mice show fully developed IBD pathology. 13 In sharp contrast to germ-free Tnf DARE/ þ mice, Crohn's-like pathology was readily evidenced in the ileum of 11-week-old control Tnf DARE/ þ mice originating from the same mouse colony and raised under identical but non-sterile, specific pathogenfree housing conditions (Figure 1a,b) . These results demonstrate that the development of Crohn's-like IBD pathology in Tnf DARE/ þ mice is microbiota-dependent. The complete microbial dependence of intestinal pathology in Tnf DARE/ þ mice suggests a possible implication of the microbiota in the very early events driving pathogenesis in this model, which are related to TNF overproduction. Relevantly, we have previously established that IECs are a major local source of early TNF overexpression in Tnf DARE/ þ mice and that mice engineered to overexpress TNF specifically by IECs develop full Crohn's-like Figure 1 Germ-free Tnf DARE/ þ mice are completely rescued from TNF overexpression in the intestine and Crohn's-like IBD pathology. (a) Histological analysis was performed in the terminal ileum of n ¼ 6 Tnf DARE/ þ mice raised under germ-free conditions at the age of 15 weeks. N ¼ 7 Tnf DARE/ þ mice raised under SPF conditions (11 weeks) were used as controls. Representative H&E-stained sections are shown. (Scale bars: 100 mm). (b) Histopathological analysis performed in the terminal ileum of germ-free and SPF control Tnf DARE/ þ mice examined at the age of 15 and 11 weeks, respectively. Statistical significance was calculated by KruskalWallis one-way analysis of variance. (c) Quantification of TNF gene expression in whole tissue biopsies from the terminal ileum of Tnf DARE/ þ mice reared under germ-free and SPF conditions, examined at the age of 15 and 11 weeks, respectively. Statistical significance was calculated with two-tailed Mann-Whitney test. All data shown represent mean±s.e.m. H&E, hematoxylin and eosin; IBD, inflammatory bowel disease; TNF, tumor necrosis factor; SPF, specific pathogen-free.
IBD pathogenesis in the ileum. 12 We examined the necessity of the intestinal microbiota in ileal TNF overexpression, by performing quantitative PCR analysis in the ileum showing significantly higher TNF expression levels in the ileum of specific pathogen-free compared with germ-free Tnf DARE/ þ mice ( Figure 1c) . These results show that microbial signals are necessary for the induction of aberrant TNF expression in the intestine, a condition sufficient for disease initiation in this model. As innate recognition of the microbiota by several Tolllike receptors initiates signaling cascades through the Myd88 adaptor molecule and activates cytokine production, including TNF, 14 (Figure 2c ). This suggests that innate response to lipopolysaccharide through Myd88 drives TNF overexpression and subsequently mediates IBD pathogenesis in Tnf DARE/ þ mice. These results establish that Toll-like receptor/Myd88-mediated innate recognition is required for TNF-driven IBD pathology development, in contrast to the homeostatic role established for Toll-like receptor/ Myd88 signaling in epithelial-injury-induced colitis, 15 and also indicate the presence of additional, Myd88-independent, innate pathways mediating TNF-driven murine Crohn's-like pathogenesis.
The inflamed ileum of Tnf DARE/ þ mice is characterized by epithelial alterations involving loss of lysozymeexpressing Paneth cells and defective antimicrobial responses High-resolution endoscopy performed in the terminal ileum of diseased Tnf DARE/ þ mice showed intestinal villi with increased diameter and an irregular shape, an observation consistent with the increased inflammatory infiltration in the LP in this model (Figure 3a) . The intestinal epithelium of diseased Tnf DARE/ þ mice is also characterized by the accumulation of aE þ CD8ab þ effector intraepithelial T-lymphocytes ( Figure 3b) . We have previously shown that these cells home to the ileum in a aEb7 integrin-dependent manner where they predominate over the resident non-conventional TCRgd and TCRabCD8aa T-lymphocytes and express interferon (IFN)-g and TNF. 16 To examine the possible effects of cytokine-expressing immune effectors on intestinal epithelial functions, we characterized barrier properties, epithelial cell type populations, and gene expression in the intestinal epithelium of diseased Tnf DARE/ þ mice. TNF and IFN-g have been suggested to promote a leaky paracellular transport of solutes across the intestinal epithelium. 17 We examined the possible presence of defects in paracellular epithelial barrier permeability in the terminal ileum of diseased Tnf DARE/ þ mice by measuring blood to lumen 51
Cr-EDTA clearance. No difference was found between Tnf DARE/ þ mice and WT littermates in the paracellular permeability for this small molecule (364 Da) in the ileum (Figure 3c ). In addition, no significant difference was found in the lumen to blood permeability of orally administered 20 kDa fluorescein isothiocyanate-dextran (Figure 3d ). Although malfunctions in the paracellular epithelial barrier in Tnf DARE/ þ mice cannot be generally excluded based on these experiments, these argue 
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MucosalImmunology | VOLUME 9 NUMBER 3 | MAY 2016 against the presence of major defects permitting the passage of luminal molecules. At the level of transcellular ion transport and ion channel function, we have previously reported defects in bicarbonate secretion and fluid absorption in the ileum of Tnf DARE/ þ mice, which may affect luminal pH and gut microbiota composition in these mice. 18 The reduced fluid absorption in the ileum is compensated in the colon of Tnf DARE/ þ mice, 18 thus no diarrhea is observed ( Figure 3e ). Quantification of Goblet cells per villus by Periodic acid-Schiff staining showed no difference between diseased Tnf DARE/ þ and WT control mice ( Figure 3f ). Furthermore, mucin 2 secretion by Goblet cells was also found similar between Tnf DARE/ þ mice and WT controls ( Figure 3g ). These results suggest that no major defects occur in the formation of the mucus barrier in the inflamed ileum of Tnf DARE/ þ mice. In contrast, Paneth cell quantification by immunostaining using anti-lysozyme antibodies revealed significantly reduced lysozyme-expressing Paneth cell numbers per crypt in the ileum of Tnf DARE/ þ mice at the age of 8 and 16 weeks, an intermediate and a full-blown disease stage, respectively ( Figure 4a ). Sixteen-week-old Tnf DARE/ þ mice show significantly reduced Paneth cells compared with 8-week-old Tnf DARE/ þ mice, indicative of an association between pathology stage and Paneth cell numbers. In addition, 8-week-old Tnf DARE/ þ mice showed significantly reduced Paneth cell numbers in crypts surrounded by extensive submucosal inflammation as compared with crypts located in areas where inflammation is less extensive or restricted in the mucosa (Figure 4b ). These results show that disease progression in Tnf DARE/ þ mice is associated with Paneth cell loss as assessed by immunostaining against lysozyme. To examine whether adaptive immune system effectors are required for this effect, we examined Paneth cell numbers in alymphoid Tnf
À / À mice show strongly attenuated pathology characterized by persistent infiltration of neutrophils in the LP and villi blunting. 13 Quantification of Paneth cells by immunostaining against lysozyme in 16-week-old Tnf DARE/ þ Rag1 À / À mice showed significantly attenuated Paneth cell loss in their ileal crypts when compared with Tnf DARE/ þ mice, to values approximating those of WT animals (Supplementary Figure S1a, c). In agreement with the previously described infiltration of neutrophils in the latter, 13 lysozyme-producing inflammatory cells were observed in the LP of both Tnf DARE/ þ and Tnf Figure S1a) . Thus, adaptive immune system effectors are essential for Paneth cell loss in Tnf DARE/ þ mice, whereas innate inflammatory infiltrates appear not to be sufficient to mediate Paneth cell loss. Furthermore, lysozyme immunostainings in 16-week-old Tnf DARE/ þ Ifng À / À mice, which also display an attenuated pathology, 13 showed a significantly attenuated Paneth cell loss compared with Tnf DARE/ þ littermate controls (Supplementary Figure S1b, c) . To examine the functional consequences of Paneth cell loss in the epithelium of Tnf DARE/ þ mice, we tested antimicrobial responses because these cells are a major source of antimicrobial peptides in the small intestine. quantitative PCR analysis performed in the ileum of 8-week-old Tnf DARE/ þ mice and littermate WT controls for a panel of antimicrobial genes showed significantly decreased expression levels for the alpha defensin genes (Defa) Defa21 and Defa29, the complement receptor type 2 (CR2) and the lysozyme-encoding gene Lyzc1 in Tnf DARE/ þ mice (Figure 4c,d) . These results suggest that IBD pathology in Tnf DARE/ þ mice is associated with diminished antimicrobial gene expression, in agreement with the loss of Paneth cells observed in these mice. To compare the above findings with inflammation levels, we measured gene expression levels of Tnf, the major driver of inflammation and pathogenesis in Tnf DARE/ þ mice. In agreement with our previous results on an early local Tnf overexpression before disease onset in this model, 12 Tnf DARE/ þ mice showed increased Tnf expression in the ileum compared with their WT littermates at 4, 8, and 18 weeks of age (Figure 4e ). Dysbiosis, increased abundance of segmented filamentous bacteria, and increased epithelial attachment of bacteria in the terminal ileum of diseased Tnf DARE/ þ mice Antimicrobial peptides can affect the composition of the intestinal microbiota. 19 To determine whether alterations in the expression of antimicrobial peptides and/or bicarbonate secretion defects observed in Tnf DARE/ þ mice altered the composition of the microbiome, we analyzed the mucosaassociated microbiome in the distal ileum of Tnf DARE/ þ and co-housed WT control littermates by 16S rDNA sequencing. 20 Before disease onset, at 4 weeks of age, no significant difference in alpha diversity, beta diversity, or the relative abundance of the different phyla was found between WT and Tnf DARE/ þ mice ( Figure 5 ). After 8 weeks of age, a progressive increase in the relative abundance of Firmicutes was observed with a concomitant significant decrease in Bacteroidetes at 18 weeks of age. This progression was accompanied by a significant decrease in alpha diversity (species richness) and significant separation of WT mice from Tnf DARE/ þ mice by weighted UniFrac analysis ( Figure 5 ). These results indicate that the composition of the microbiome in the ileum of diseased Tnf DARE/ þ mice and co-housed WT control littermates is markedly different. Detailed analysis of the 16S rDNA sequencing data revealed the presence of 139 operational taxonomic units (OTUs) present across the different samples after filtering (average read fraction 92±7%). At 4 and 8 weeks of age, none of these OTUs was significantly different between co-housed Tnf DARE/ þ mice and WT littermate controls ( Figure 6, Supplementary Figure S2) Figure S2 ). These two OTUs both belonged to the phylum Firmicutes and the genus Candidatus Arthromitus or Candidatus Savagella, 21 informally known as segmented filamentous bacteria (SFB). These results show that at 18 weeks of age, compared with co-housed WT littermate controls, Tnf DARE/ þ mice have an increased relative abundance of SFB in the terminal ileum.
The dysbiosis associated with the loss of Paneth cells and defects in antimicrobial genes expression observed in diseased Tnf DARE/ þ mice may affect not only the composition but also the number of mucosa-associated bacteria. We performed fluorescence in situ hybridization analysis using a eubacterial probe on terminal ileal sections obtained from Tnf DARE/ þ and WT littermate controls. We observed an increased number of bacteria in direct contact with IECs in Tnf DARE/ þ mice compared with WT controls (Figure 7a,b) . To confirm these results, we quantified the number of bacteria by pan-bacterial 16S rDNA quantitative PCR analysis. While the levels of bacterial 16S rDNA in the stool were not significantly different between WT and Tnf DARE/ þ mice (Figure 7c) , an increased number of mucosa-associated bacteria was detected in Tnf DARE/ þ compared with WT animals (Figure 7d) . Similar results were obtained using SFB-specific primers, 22 i.e., Tnf DARE/ þ mice showed an increase in the levels of mucosa-associated SFB (Figure 7e) . These results suggest that in diseased Tnf To determine whether we can affect Crohn's-like disease progression by modulating the microbiota at an early disease stage, we treated Tnf DARE/ þ mice with water or with 0.5 g l À . vancomycin in the drinking water. Antibiotic treatment was initiated at 6 weeks of age, an early disease stage when the first signs of pathology are observed, and maintained until analysis at 20 weeks of age, when full-blown disease is expected (Figure 8a) . Histopathological analysis showed severe Crohn's-like disease in Tnf DARE/ þ mice treated with water (n ¼ 5). In contrast, none of the Tnf DARE/ þ mice treated with antibiotics (n ¼ 5) showed signs of a Crohn's-like disease (Figure 8b-d) . These results establish the critical role of the microbiota in the progression of Crohn's-like IBD and also highlight the therapeutic potential of microbiota modulation by antibiotics when administered at the early stages of chronic intestinal inflammation.
DISCUSSION
The results presented in this study collectively provide a mechanistic interpretation of the complex host-microbiota dialogue in Crohn's disease pathogenesis modeled in Tnf DARE/ þ mice. First, we show that Crohn's-like IBD pathology in the Tnf DARE model is microbiota-dependent, originating from TNF overexpression in the intestine, which is driven by a normal, indigenous microbiota. Second, we show that Crohn's-like IBD pathology in Tnf DARE/ þ mice is associated with dampened antimicrobial responses and reduction of Paneth cells, mediated by adaptive immune system effectors. We further establish that secondarily to disease, these conditions shape a dysbiotic gut microbiota in Tnf DARE/ þ mice which is not sufficient to transfer disease to co-housed WT mice but also involves increased abundance of epithelial-adhering SFB, which may further promote disease.
Concerning our first conclusion that Crohn's-like IBD pathogenesis in Tnf DARE/ þ mice is microbiota-dependent, studies performed in other animal models of IBD, mainly in colitis models, have been controversial so far. Thus, an essential role in colitis pathogenesis has been shown for the microbiota in IL-10 À / À mice and in HLA-B27 transgenic rats, which were completely rescued from colitis under germ-free conditions. 23, 24 In contrast, germ-free conditions attenuated but did not prevent spontaneous pathology in the IL-2 À / À mouse model of colitis. 25 The role of the microbiota in murine ileitis was examined so far only in the SAMP1/YitFc model in which germ-free conditions led to an attenuated phenotype but did not prevent pathogenesis. 26 Consistently with the fact that adaptive immune effectors are a primary cause of disease in this model bearing transferable pathogenic activity, 27 the persistence of the SAMP1/YitFc ileal pathology under germ-free conditions has been attributed to defects in immunoregulation. 26 These studies indicate the presence of microbiotaindependent mechanisms sufficient for IBD pathogenesis, particularly when adaptive immune responses are deregulated. In contrast, the microbiota is indispensable for the development of ileitis in the Tnf DARE model where innate and adaptive immune responses form a continuum. Although aberrant adaptive immune responses are an important component of the fully developed IBD pathology in Tnf DARE/ þ mice, 16 ileal pathology is observed in Tnf DARE/ þ Rag1 À / À mice, involving infiltration of neutrophils and villi blunting. 11, 13 Thus, germfree studies in mouse models of IBD collectively suggest that the microbiota is indispensable for pathogenesis when deregulated inflammatory mechanisms predominate. By contrast, when aberrant adaptive immune responses are the major driver of disease, the microbiota appears to be dispensable for pathology initiation.
Our second conclusion is that Crohn's-like pathogenesis in Tnf DARE/ þ mice relies on the commensal microbiota, whereas global changes in microbial communities, referred to as dysbiosis, are secondary to disease. This conclusion stems from our findings that significant alterations in gut microbiota composition at the level of phyla and at the level of the individual OTUs detected are observed only in late disease in Tnf DARE/ þ mice and thus appear not to be essential for the initiation of IBD pathogenesis. By contrast, the commensal microbiota is highly potent in inducing local TNF expression in the intestine of WT mice and TNF overexpression in the intestine of Tnf DARE/ þ mice at an early time-point, before disease onset. An important question raised by these findings is whether TNF transcriptional activation in the gut depends on specific bacterial taxa within the indigenous microbiota. Bacteria within commensals which are highly potent in inducing TNF transcriptional activation would function as pathobionts in the context of TNF-dependent ileitis in Tnf DARE/ þ mice, 28 in a similar manner to the role played by Prevotellaceae in colitis susceptibility in Nlrp6 À / À mice for example. 29 The identification of such pathobionts could provide alternatives for localized targeting of TNF secretion in the gut. Thus, commensals or specific pathobionts within commensals, and not necessarily an overall dysbiotic microbiota, may be highly relevant to the early events initiating Crohn's disease, particularly in the presence of genetic variants, which, either directly or indirectly, promote pro-inflammatory activation and local TNF expression in the gut.
Our present results, however, do not exclude a possible disease-exacerbating function of the dysbiotic microbiota developed in diseased Tnf DARE/ þ mice. In the T-bet
À / À mouse model of colitis, the dysbiotic microbiota has been shown to be colitogenic and, interestingly, this activity is transferable even to WT mice. 30 Although the dysbiotic microbiota of Tnf DARE/ þ mice is not sufficient to transfer pathology in co-housed WT mice, the findings in the T-bet
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À / À model indicate that the inflamed intestine may privilege the development of particularly harmful bacterial strains that may also bear full pathogenic potential. The increased abundance of SFB and their epithelial attachment in the inflamed ileum of Tnf DARE/ þ mice may contribute to disease perpetuation in this model. SFB have been shown to both induce Th17 cells in the LP and tightly adhere to the surface of epithelial cells in the terminal ileum of mice bearing Th17 cells. 31 We have previously shown that Tnf DARE/ þ mice display increased Th17 responses in the ileal LP compared with WT controls. 16 It is likely that the increased SFB abundance and their epithelial attachment in the ileum, reported here, underlie the increased Th17 responses in Tnf DARE/ þ mice. The dysbiosis and the increased bacterial attachment on the epithelium observed in Tnf DARE/ þ mice secondarily to pathogenesis can be largely explained by the loss of Paneth cells and the associated disturbances in the expression of antimicrobial peptide genes. Paneth cells have a key role in intestinal antimicrobial surveillance, host defense, and homeostasis and the involvement of Paneth cell dysfunction in IBD pathophysiology is under intense investigation, in light of genome-wide association studies results indicating abnormalities in Paneth cell function as risk factors for disease. 3 Paneth cells in Crohn's disease patients have been shown to strongly overexpress TNF, a fact indicating that these cells have the potential to introduce inflammatory signals in the intestinal mucosa under some conditions. 32 Reduced Paneth cell alpha defensins are observed in the ileum of Crohn's disease patients, though not in association with inflammation grade. 33 In addition, in agreement with early reports, 34 patients with active Crohn's disease have recently been shown to display reduced numbers of Paneth cells in their crypts, a defect suggested to result from increased necroptotic Paneth cell death. 35 Whether the loss of lysozyme þ cells in Tnf DARE/ þ mice reflects Paneth cell death or a dysfunction of live Paneth cells needs to be addressed in future studies. It is likely that the loss of lysozyme þ Paneth cells in Tnf DARE/ þ mice is caused by IFN-g and TNF, both overproduced in their inflamed ileum. TNF has been shown to trigger Paneth cell necroptosis in mice bearing epithelial-specific caspase-8 ablation, 35 whereas acute exogenous TNF administration in normal mice leads to Paneth cell dysfunction and loss of cellular integrity. 36 In addition, IFN-g produced during mucosal responses against the protozoan parasite Toxoplasma gondii leads to the reduction of Paneth cells. 37 IFN-g is also a trigger for Paneth cell degranulation, epithelial extrusion, and death, in organoids and in vivo upon anti-CD3 antibody injection. 38 However, the physiological context of murine ileitis is markedly different from the above models; thus, the requirement of TNF and IFN-g for Paneth cell loss should be directly examined by Paneth cell-specific ablation of the respective receptors in Tnf DARE/ þ mice. A study published while our paper was under peer-review 39 showed that Tnf DARE ileitis is microbiota-dependent and associated with dysbiosis; results that are in agreement with our results. Schaubeck et al. also concluded that Tnf DARE ileitis is transmissible by disease-associated but not healthy microbiota. This conclusion was based on the fact that germ-free Tnf DARE/ þ mice developed ileitis upon caecal content transfer from diseased but not from non-responder (healthy) Tnf DARE/ þ mice present in their colony; transfer from WT mice was not tested. The authors did not explain, however, why diseased Tnf DARE/ þ mice did not transmit ileitis to the co-housed non-responders of the same litter, a fact that argues against a transmissible phenotype. Therefore, the evidence presented in the work by Schaubeck et al. was not firmly conclusive as to whether ileitis is transmissible in the Tnf DARE model by disease-associated but not healthy microbiota and that intestinal pathology is secondary to dysbiosis.
Our study establishes a mouse model of Crohn's disease in which the indigenous intestinal microbiota is causatively involved in pathogenesis under genetic conditions favoring TNF overexpression. In this model, dysbiosis is a result and not a cause of intestinal pathology. Future studies may clarify whether in humans, the indigenous microbiota has the potential to have a similar pathogenic role in the presence of genetic conditions that favor inflammatory activation in the gut or affect the antimicrobial defenses that normally maintain commensals at check. Figures 5-8 ) under specific pathogen-free conditions. As an exception, Tnf DARE/ þ Ifng À / À mice were maintained on a mixed C57BL/6J Â 129Sv genetic background in the animal facilities of BSRC ''Alexander Fleming''.
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À / À mice, 41 and Ifng À / À mice 42 have been previously described as indicated. For all in vivo experiments, littermate and sex-matched mice were used. Mice were randomly assigned to experimental groups on a first-come basis. No mice were excluded from analyses performed. Tnf DARE/ þ mice were analyzed before disease onset (4 weeks) and/or at an intermediate (8 weeks) , established (12 weeks), or full-blown (Z16 weeks) disease stage, based on the previously described disease course for this model in the animal facilities of BSRC ''Alexander Fleming''. 13 A similar Tnf DARE/ þ disease course was observed in the animal facilities of Icahn School of Medicine at Mount Sinai as shown in Supplementary Figure S3 .
All mice were used in accordance with the guidance of the Institutional Animal Care and Use Committee of BSRC ''Alexander Fleming'' and the guidelines of the Animal Care and Use Committee of Icahn School of Medicine at Mount Sinai.
Generation of germ-free Tnf DARE/ þ mice. Germ-free mice were generated and raised at the Instituto Gulbenkian de Ciência, Oeiras, Portugal. C57BL6J Tnf DARE/ þ and WT mice were transferred to germ-free conditions upon rederivation by caesarean section, as described in the relevant EMMA protocol (http://strains.emmanet.org/protocols/GermFree_0902.pdf). Briefly, 20 days post-coitum donor females were killed and their uteri transferred to a sterile chamber through a reservoir filled with 1% VirkonS (Sigma-Aldrich, Steinheim, Germany). Pups were extracted and adopted by C3H/HeN Germ-Free foster mothers. The microbiological status of the isolator and the animals were monitored 3 weeks after transfer and every 3 weeks onward. Germ-free and specific pathogen-free control Tnf DARE/ þ mice were raised and maintained under strictly identical conditions, except the microbiological status. These include food pellets, drinking water, humidity, and temperature. mice and of germ-free Tnf DARE/ þ mice was performed in the terminal ileum as described previously. 12 The proximal and distal colon was also examined. Briefly, the tissue was embedded in paraffin and stained with hematoxylin and eosin. Semi-quantitative assessment of intestinal pathology was performed in a blinded manner. The following scoring system was used: 0 ¼ normal, 1 ¼ villi blunting and mucosal inflammation, 2 ¼ villi blunting, extensive mucosal inflammation, and submucosal inflammation, 3 ¼ extensive submucosal inflammation, 4 ¼ transmural inflammation.
Pan-bacterial PCR amplification. Total genomic DNA was isolated from tissue using the DNeasy Blood & Tissue Kit (QIAGEN, Valencia, CA). Quantitative PCR analysis and SFB primer sequences are described elsewhere. 43 Relative quantity was calculated by the DCt method and normalized by the presence of mouse ubiquitin.
Biome analysis. DNA was obtained from distal ileum (2 cm) using the DNeasy Blood and Tissue Kit (QIAGEN). Bacterial 16S rRNA genes were amplified using the primers as described. 44 Sequencing was performed with an Illumina (San Diego, CA) MiSeq sequencer for sequencing as previously described. 44 Detailed methods for DNA Extraction, 16S rDNA Amplification, Multiplex sequencing, and Analysis of 16S rDNA Sequences are provided in the Supplementary Methods. Statistical analyses. For graphs and statistical analyses indicated, we used GraphPad Prism, SigmaPlot, or R statistical environment. Sampling distributions were tested for normality with a threshold of alpha ¼ 0.05 (GraphPad Prism). For Po0.05 in the normality test, differences in means were tested for statistical significance with twotailed Mann-Whitney U test (Wilcoxon rank-sum test). For P40.05 in the normality test, F test or Bartlett's test were used for homoscedasticity. For similar variances (F test, P40.05), unpaired twotailed Student's t-test was applied; for unequal variances (F test, Po0.05), unpaired two-tailed Welch's t-test was applied. P-values o0.05 were considered as statistically significant.
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